KPWS
ABBV icon

Kestra Private Wealth Services’s AbbVie ABBV Stock Holding History

Kestra Private Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.5M Buy
177,186
+5,266
+3% +$1.17M 0.48% 36
2025
Q4 		$39.3M Buy
171,920
+829
+0.5% +$189K 0.49% 33
2025
Q3 		$39.6M Buy
171,091
+7,387
+5% +$1.5M 0.52% 30
2025
Q2 		$30.4M Buy
163,704
+10,179
+7% +$1.89M 0.44% 39
2025
Q1 		$32.2M Buy
153,525
+5,423
+4% +$1.05M 0.54% 35
2024
Q4 		$26.3M Buy
148,102
+8,835
+6% +$1.62M 0.45% 38
2024
Q3 		$27.5M Buy
139,267
+861
+0.6% +$161K 0.5% 35
2024
Q2 		$23.7M Buy
138,406
+21,793
+19% +$3.61M 0.48% 38
2024
Q1 		$21.2M Buy
116,613
+307
+0.3% +$52.9K 0.48% 40
2023
Q4 		$18M Buy
116,306
+7,289
+7% +$1.06M 0.46% 42
2023
Q3 		$16.3M Buy
109,017
+9,011
+9% +$1.32M 0.51% 40
2023
Q2 		$13.5M Buy
100,006
+1,371
+1% +$201K 0.46% 45
2023
Q1 		$15.7M Buy
98,635
+8,021
+9% +$1.23M 0.63% 26
2022
Q4 		$14.6M Buy
90,614
+368
+0.4% +$56.4K 0.74% 20
2022
Q3 		$12.1M Buy
90,246
+2,026
+2% +$291K 0.7% 19
2022
Q2 		$13.5M Sell
88,220
-6,812
-7% -$1.04M 0.77% 15
2022
Q1 		$15.4M Buy
95,032
+4,194
+5% +$609K 0.76% 16
2021
Q4 		$12.3M Buy
90,838
+2,247
+3% +$265K 0.59% 25
2021
Q3 		$9.56M Buy
88,591
+24,508
+38% +$2.8M 0.53% 30
2021
Q2 		$7.22M Buy
64,083
+5,986
+10% +$674K 0.44% 40
2021
Q1 		$6.29M Buy
58,097
+2,180
+4% +$233K 0.44% 51
2020
Q4 		$5.89M Sell
55,917
-830
-1% -$79.8K 0.43% 49
2020
Q3 		$4.98M Buy
+56,747
New +$5.34M 0.43% 54

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kestra Private Wealth Services's ABBV Position: Q1 2026 in Review

Kestra Private Wealth Services increased its AbbVie (ABBV) stake by 3.1% in Q1 2026, buying an estimated $1.17M and bringing the position to 177,186 shares worth $38.5M. The position accounts for 0.48% of the portfolio, ranked #36.

Kestra Private Wealth Services first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $39.6M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kestra Private Wealth Services held 177,186 shares of AbbVie worth $38.5M as of Q1 2026.
  • Kestra Private Wealth Services bought 5,266 AbbVie shares in Q1 2026, an estimated $1.17M.
  • AbbVie made up 0.48% of Kestra Private Wealth Services's portfolio in Q1 2026, its #36 holding.
  • Kestra Private Wealth Services first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
  • Kestra Private Wealth Services's AbbVie position peaked at $39.6M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.